Back to search
FDAFDA · Food and drugs·Recall number D-1140-2015

Lamivudine and Zidovudine Tablets USP 150mg/300mg 30 Unit Dose Blisters, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton of 30: NDC 68084-0416-21, Individual dose: NDC 68084-0416-11

Published June 24, 2015 · Recall initiated: March 2, 2015

Summary

FDA records drug Class II recall D-1140-2015, published June 24, 2015 and initiated March 2, 2015. Recalling firm: American Health Packaging; Status: Terminated; Reported quantity: 925 cartons (30 tablets in each carton); Lot: Lot #140849. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
American Health Packaging
Distributor
Nationwide
Lot
Lot #140849
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lamivudine and Zidovudine Tablets USP 150mg/300mg 30 Unit Dose Blisters, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton of 30: NDC 68084-0416-21, Individual dose: NDC 68084-0416-11 recalled?

Yes. FDA published recall D-1140-2015 on June 24, 2015. Reported hazard: Failed dissolution specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter